|
US2017022211A1
|
|
O-demethylating process of methoxy substituted morphinan-6-one derivatives
|
|
WO2011113476A2
|
|
Method for producing 2'-deoxyadenosine compounds
|
|
WO2011003455A1
|
|
Method for producing 4-(alkyl)-1-(2-methyl-3-(2,6-dimethylmorpholine)propyl) benzol compounds
|
|
JO3022B1
|
|
Method of producing 2'-deoxy-5-azacytidine (decitabine)
|
|
US2011144346A1
|
|
Method for producing n-phenyl-n-(4-piperidinyl) amide salts
|
|
EP2167506A2
|
|
Method for producing n-methylnaltrexone bromide
|
|
EP2048151A1
|
|
Method for producing nucleosides by direct glycosylation of the nucleoside base
|
|
EP2050757A1
|
|
Method of producing 2' -deoxy-5-azacytidine (Decitabine)
|
|
WO2008138383A1
|
|
Method for the production of n-methyl naltrexone bromide
|
|
WO2008131567A1
|
|
Solvent-free crystalline form of naltrexone
|
|
EP1814617A1
|
|
Device, in particular, a medical device, for administering an active substance, in particular in the form of a plastic dual-chambered syringe
|
|
EP1713768A2
|
|
Novel crystalline forms of entacapone and production thereof
|
|
BRPI0404193A
|
|
Tramadol prolonged release formulation
|
|
WO2005116046A1
|
|
Method for producing an iron sucrose complex
|
|
AU2004319676A1
|
|
Method for producing iron (III) gluconate complex
|
|
WO2005075488A1
|
|
Method for producing sodium fosphenytoin
|
|
AU2003287844A1
|
|
Novel crystalline forms of entacapone, and production thereof
|
|
MXPA05006210A
|
|
Controlled release preparations comprising tramadol and topiramate.
|
|
BR0316853A
|
|
Stable topiramate formulations
|
|
CA2489295A1
|
|
Spherical pellet containing a water-soluble active ingredient
|
